Correspondence robert.ihry@novartis.com (R.J.I.), akaykas@gmail.com (A.K.) In Brief Ihry et al. develop a CRISPR/Cas9 genetic screening platform for hPSCs that enables unbiased genome-scale genetic screening. The platform exhibits high performance and accurately detects the dropout of essential genes. Furthermore, proof-of-concept screens exploit hPSCspecific phenotypes to identify regulators of fitness, survival after single-cell dissociation, and pluripotency.
INTRODUCTION
Human pluripotent stem cells (hPSCs) can be used to generate a wide variety of disease-relevant cell types and have the potential to improve the translation of preclinical research by enhancing disease models. Despite the huge potential, genetic screening using hPSCs has been limited by their expensive and tedious cell culture requirements (Chen et al., 2011) and reduced genetic manipulation efficiencies . Only a few short hairpin RNA (shRNA) screens have been conducted in hPSCs (Chia et al., 2010; Zhang et al., 2013) , but shRNAs have a high level of off targets and do not cause a complete loss of function, which is difficult to interpret (DasGupta et al., 2005; Echeverri et al., 2006; Kampmann et al., 2015; McDonald et al., 2017) . Currently, the CRISPR/Cas9 system is the genetic screening tool of choice because it can efficiently cause loss-of-function alleles (Jinek et al., 2012; Cong et al., 2013; Mali et al., 2013) . Hundreds of genome-scale pooled CRISPR screens have been performed in immortalized human cell lines (Hart et al., 2015; Wang et al., 2015; Meyers et al., 2017) . However, in hPSCs the CRISPR/Cas9 system has been used primarily for small-scale genome engineering (Merkle et al., 2015) . In genetically intact hPSCs, the only genome-scale CRISPR screen to date used methods developed for cancer cells, suffered from technical issues, had poor performance, and identified few developmentally relevant genes (Hart et al., 2014; Shalem et al., 2014) . We addressed these technical issues by systematically tailoring the CRISPR/Cas9 system for hPSCs . We developed a doxycycline (dox)-inducible Cas9 (iCas9) hPSC line and stably infected it with a genome-scale single guide RNA (sgRNA) library. We banked and expanded the CRISPR-infected hPSC library in the absence of editing (Àdox), which enabled us to generate a renewable stem cell pool with stable but inactive sgRNAs. This allowed us to conduct multiple independent screens with the same cell library.
In the first screen, we identified genes that suppress or enhance hPSC fitness over long-term culture. Although previous screens have generated gold-standard gene lists of core-essential genes that reduce cell survival when mutated, little is known about the mutations that enhance survival and proliferation. Unlike coreessential genes, these enhancing mutations appear to be cell type specific, and no consistent lists exist for this type of gene (Hart et al., 2014) . In hPSCs, karyotypic analysis has detected recurrent copy number variations (CNVs) that confer a growth advantage (Amps et al., 2011; Laurent et al., 2011) ; however, these studies lack gene level resolution. Recently, next-generation sequencing of hundreds of hPSCs identified the recurrence of dominant-negative TP53 mutations that can expand within a population of hPSCs (Merkle et al., 2017) . We mined our data for gene knockouts that enriched in culture and identified many genes, including components of the TP53 pathway and other known tumor suppressors. We validated the strongest hit, PMAIP1/NOXA, which appears to be a stem cell-specific gene conferring sensitivity to DNA damage downstream of TP53.
In the second screen, we identified genes required for singlecell cloning. hPSCs have a poor survival rate after dissociation to single cells, which is detrimental for genome engineering. Multiple groups have extensively characterized death induced by single-cell cloning and have demonstrated the process is similar to but distinct from anoikis and is triggered by a ROCK/myosin/ actin pathway (Chen et al., 2010; Ohgushi et al., 2010) . To prevent death, hPSCs are passaged as clumps or treated with ROCK inhibitors (Watanabe et al., 2007) . By subjecting our hPSC mutant library to single-cell dissociation without ROCK inhibitors, we selected for mutations that survive single-cell cloning. sgRNAs for the ROCK and myosin pathways were enriched in the surviving clones. The most enriched gene was the proapoptotic regulator PAWR (Burikhanov et al., 2009) . Validation studies confirmed a role for PAWR as a component of the actin-cytoskeleton that induces membrane blebbing and cell death caused by single-cell cloning. The additional genes identified here will further our understanding about the sensitivity of hPSCs to single-cell cloning.
In the final screen, we used a fluorescence-activated cell sorting (FACS)-based OCT4 assay to identify regulators of pluripotency and differentiation. Pluripotency is a defining feature of hPSCs, and it allows them to differentiate into all three germ layers. OCT4/POU5F1, NANOG, and SOX2 are critical transcription factors that maintain pluripotency in vivo and in vitro (Nichols et al., 1998; Chambers et al., 2007; Masui et al., 2007) . OCT4 and SOX2 overexpression is commonly used to reprogram somatic cells toward the pluripotent state (Takahashi and Yamanaka, 2006; Takahashi et al., 2007; Yu et al., 2007) . By isolating mutant cells with high or low OCT4 protein expression, we identified many genes involved in maintaining the pluripotent state, along with genes involved with induction of differentiation.
By using an iCas9 hPSC line stably infected with a genomescale lentiCRISPR library, we were able to bank a CRISPRhPSC library that was renewable and enabled a large number of independent screens with the same starting library. This allows direct comparison between screens and reduces screen to screen variability. We rigorously tested the system and identified genes important for fitness, single-cell cloning, and pluripotency of hPSCs. Herein we provide a resource with detailed methods and all available data including many genes that are involved in hPSC biology. This resource will serve as a parts list of genes that are functionally important for the human stem cell state. These lists of genes provide unique insights into the genetic regulation of human development that could only be identified in normal diploid cells that are not transformed or cancerous. Furthermore, the gene sets and methods will increase our systematic knowledge of hPSC biology and will enable additional large-scale CRISPR screens in stem cells and their somatic derivatives.
RESULTS
The iCas9 System Is a Self-Renewing Resource Enabling Successive Genome-wide Genetic Screens in hPSCs We set out to develop a high-throughput CRISPR/Cas9 platform for hPSCs that would enable successive rounds of screening from a stable library of lentiCRISPR-infected hPSCs ( Figures  1A and S1 ). Generating a genome-scale lentiCRISPR hPSC library would enable both the rigorous testing of CRISPR screen performance and the identification of cell type-specific regulators of the pluripotent state. In our previous work, we developed an all-in-one iCas9 transgene that was inactive in the absence of dox . The tight control over Cas9 expression allowed us to transduce cells with lentiviruses expressing sgRNAs (lentiCRISPRs) in the absence of dox without causing on-target indels. We tested if it was possible to bank a genome-scale lentiCRISPR-infected cell library ($5 sgRNAs per gene, 91,725 total sgRNAs) prior to Cas9 mutagenesis (Àdox). After one freeze-thaw cycle, next-generation sequencing (NGS) analysis revealed no bottlenecking of the library demonstrating the feasibility of banking a large lentiCRISPR hPSC library for repeated screens ( Figure 1B ).
Evaluating the Performance of CRISPR Screening in iCas9 hPSCs
Next, we performed a fitness screen to evaluate the global performance of the system ( Figure 1C) . We benchmarked the performance of the screen by using annotated lists of core-essential genes. Core-essential genes are required for the survival of all cells; the corresponding CRISPR knockout causes the sgRNAs to be depleted (Hart et al., 2014 (Hart et al., , 2015 . Genome-scale CRISPR screening in hPSCs has been challenging (Hart et al., 2014; Shalem et al., 2014) . hPSCs have a strong DNA damage response (DDR), and Cas9-induced double-strand breaks (DSBs) cause a significant cell loss . Failure to account for Cas9-induced cell loss is problematic for pooled screening, because it is critical to maintain representation of each sgRNAbarcoded cell. Our previous work demonstrated a range of Cas9-induced cells loss between 3-and 10-fold across many sgRNAs . To reduce the bottlenecking of the sgRNA library caused by Cas9-induced toxicity, we started the screen in hPSCs at an average of 1,200 cells per sgRNA (a total of 110 million infected cells). By doing this we maintained about 4-fold more cells than a typical cancer screen (Hart et al., 2015) . During the fitness screen, DNA was sampled before and after dox exposure at days 0, 8, 14, and 18 ( Figure S1 ). To provide a qualitative measurement of screen performance, we plotted the p values calculated by the redundant small interfering RNA (siRNA) activity (RSA) test against Q1 based Z scores for a set of core-essential and non-essential genes Hart et al., 2014) . Before dox treatment the non-essential and core-essential genes are randomly distributed within a tight cluster ( Figure 1D ). After 18 days of Cas9 treatment, the distribution spreads, and the essential genes significantly drop out while the non-essential genes remain constant ( Figure 1D ; Tables S1  and S2) .
To quantify performance, we used the Bayesian analysis of gene essentiality (BAGEL) algorithm, which calculates a Bayes (Hart et al., 2015) . 405 of the hPSCs depleted genes overlap, while the remaining 365 are specifically depleted in pluripotent stem cells. (H) Genes that dropout in CRISPR screen are abundantly expressed. The y axis depicts the log 2 transformation of average TPM values from 20 independent RNA-seq experiments in H1-hESC. For each box blot, the median is depicted by white line flanked by a rectangle spanning Q1-Q3. The x axis depicts gene categories. In blue are non-essential genes from Hart et al. (2014) , in pink are 405 coreessential genes, in purple are 365 stem cell-specific essential genes, and in gray are the remaining unannotated genes. See also Figure S1 .
factor for each gene by determining the probability that the observed fold change for a given gene matches that of known essential genes (Hart and Moffat, 2016) .This generates a ranked list of Bayes factors for each gene, which can then be used to quantify screen performance by precision versus recall analysis. In a high-performance screen, essential genes have high Bayes factor scores, and the precision versus recall curve gradually drops off as analysis of the ranked list is completed. In contrast, a poor-performing screen has a precision versus recall curve that rapidly drops off, indicating many false positives (non-essential genes) with high Bayes factor scores. The sample without dox exposure (untreated) has a randomly ranked Bayes factor list with non-essential and essential genes interspersed and exhibits a poor precision versus recall curve ( Figure 1E ). In the day 18 Cas9 (+dox) treated samples, essential genes and non-essential genes segregate from each other and generates a high-performing precision versus recall curve that gradually drops off (Figure 1E ; Table S3 ). After 18 days of Cas9 exposure, we identified 770 fitness genes at a 5% false discovery rate on the basis of the precision calculation ( Figure 1F ; Table S4 ). Comparing the set of 770 hPSC fitness genes with 1,580 core-essential genes from cancer lines revealed an overlap of 405 genes ( Figure 1G ) (Hart et al., 2015) . The remaining 365 specifically dropped out in hPSCs. Both the core and hPSC-specific essential genes are abundantly expressed in hPSCs, further supporting that they are required to maintain hPSCs in culture ( Figure 1H ). Our fitness screen in hPSCs correctly identifies the dropout of core-essential genes with accuracy that is on par with CRISPR screens conducted in cancer cell lines. This demonstrates that cancer cells and stem cells share a common set of core-essential genes that can be used to benchmark performance. By accounting for cell loss caused by Cas9 activity, we limited the effects of Cas9-induced toxicity that have thwarted previous attempts at genome-scale screening in hPSCs (Hart et al., 2014; Shalem et al., 2014) . This demonstrates that it is possible to conduct an effective genome-scale CRISPR screen in hPSCs using the methods described here.
TP53 Pathway Mutations Specifically Enrich during CRISPR Fitness Screen in hPSCs
Curated lists of genes that enhance fitness during a CRISPR screen do not exist, making it difficult to benchmark the enrichment results (Hart et al., 2015) . By comparing the top $1,000 depleted (RSA-down < À2.25; Table S2 ) and enriched (RSA-up < À2.25; Table S5 ) genes, we observed that 31.8% (301 of 946) of the enriched genes were located on the X and Y chromosomes (H1-human embryonic stem cells [hESCs] XY; Figure S3 ). In contrast, the depleted genes were evenly distributed across all chromosomes. It became apparent that allosome-targeting sgRNAs were behaving similarly to non-targeting controls, which enrich during a CRISPR screen in hPSCs . We observed that sgRNAs causing a single DSB on the X chromosome are less toxic relative to sgRNAs inducing two DSBs at the MAPT locus despite being able to efficiently induce indels ( Figure S2 ). sgRNAs targeting genomic amplifications in cancer cell lines exhibit a strong depletion irrespective of the gene targets (Aguirre et al., 2016; Munoz et al., 2016; Meyers et al., 2017) . Unlike cancer cell lines, H1-hESCs with a normal diploid karyotype are very sensitive to DNA damage, making the difference between one and two DSBs significant. After recognizing that the enrichment of sgRNAs on the X and Y chromosomes was related to DSB sensitivity and copy number differences in male H1-hESCs, we focused on autosomal genes. In the remaining list of 645 autosomal genes that were enriched (RSA-up À2.25), we identified 41 tumor suppressor genes (Zhao et al., 2016) .
The second most enriched gene was TP53, which confirms the selective pressure imposed by Cas9-induced DSBs in hPSCs during a CRISPR screen ( Figure 2A ). Consistent with this TP53 mutants are able to suppress cell loss induced by Cas9 activity . Throughout the 18-day screen, the representation of sgRNAs targeting TP53 (chromosome [Chr.] 17), the checkpoint kinase CHEK2 (Chr. 22), and the pro-apoptotic regulator PMAIP1 (Chr. 18) increased in a time-dependent manner ( Figure 2B ). Database mining for associations with TP53 among the enriched genes identified 20 genes with direct connections to TP53 ( Figure 2C ; Table S6 ), 19 of which are expressed in H1-hESC and are on autosomal chromosomes. Although EDA2R is on the X chromosome, it was included because its mRNA increases in response to DNA damage in hPSCs . We hypothesized that these genes could include additional regulators responsible for the extreme sensitivity to DNA damage in hPSCs.
PMAIP1 was the most enriched gene in the screen. PMAIP1 has been implicated in TP53-dependent cell death and functions by sensitizing cells to apoptosis by antagonizing the antiapoptotic protein MCL1 at the mitochondria (Kim et al., 2006; Ploner et al., 2008; Perciavalle et al., 2012) . PMAIP1 is highly expressed in hPSCs, and its expression marks the pluripotent state (Mallon et al., 2013) . We confirmed this by examining PMAIP1 expression in two induced pluripotent stem cell (iPSC) and two hESC lines. Analysis of RNA sequencing (RNA-seq) experiments confirmed that PMAIP1 was highly expressed during the pluripotent state and drops during neuronal differentiation using the NGN2 transgene ( Figure 3A ). Additionally, Genotype-Tissue Expression (GTEx) data revealed that PMAIP1 has a highly restricted expression pattern and is not expressed in most tissues (GTEx Analysis Release V7). Although it has been demonstrated that PMAIP1 expression is maintained by OCT4 in testicular germ cell tumors (Gutekunst et al., 2013) , no functional connection has been made in hPSCs. We tested if PMAIP1 expression was maintained by the pluripotency network by differentiating cells or knocking out OCT4. Under these conditions qPCR detected a significant decrease in PMAIP1 mRNA ( Figure 3B ). In thymocytes, PMAIP1 mRNA is induced by TP53 (Khandanpour et al., 2013) . We knocked out TP53 in hPSCs but did not detect a reduction in PMAIP1 mRNA ( Figure 3B ). hPSCs constitutively express high levels of PMAIP1, and DNA damage does not increase PMAIP1 expression, further supporting PMAIP1 mRNA as pluripotency dependent and TP53 independent .
Prior work demonstrated that cancer cell lines have a reduced DDR relative to hPSCs . Consistent with this, we did not observe an enrichment of PMAIP1 sgRNAs in 14 independent CRISPR screens conducted in cancer cell lines despite using libraries containing the same PMAIP1-targeting sgRNAs ( Figure 3C ). This suggested that PMAIP1 is responsible for making hPSCs sensitive to DNA damage. To test the functional consequences of PMAIP1 mutations, we knocked out PMAIP1 in the iCas9 cell line using transient exposure to synthetic crRNAs ( Figure S3 ). We tested if PMAIP1 mutants were resistant to DSB-induced death by using lentiCRISPRs to deliver a sgRNA targeting MAPT, a neuronal gene not expressed in hPSCs. In the absence of Cas9 (Àdox), both control and PMAIP1 mutant iCas9 cells grow at a similar rate while expressing an sgRNA. In the presence of Cas9 (+dox) and a sgRNA, control cells die, while PMAIP1 mutants are able to survive despite efficient DSB induction ( Figures 3D, S3 , and S4E). qPCR analysis of the TP53-target genes P21 and FAS detected an elevated expression in PMAIP1 mutants compared with controls ( Figure 3E ). Despite having an active TP53, PMAIP1 mutants survive. This indicates PMAIP1 is downstream of TP53 activation and is consistent with its known role as a sensitizer to apoptosis (Ploner et al., 2008) . In hPSCs, cell death is the predominant response to DNA damage. Unlike PMAIP1 mutants, P21 mutants (>80% indels) are unable to suppress DSB-induced toxicity ( Figure S4E ), and P21 sgRNAs did not enrich in H1-hESCs. In contrast, in a genome-scale screen in retinal pigment epithelial cells, where Cas9 activity causes TP53-dependent cell-cycle arrest rather than apoptosis, sgRNAs targeting TP53 and P21/CDKN1A were enriched, while PMAIP1 sgRNAs were not (Table S5) (Haapaniemi et al., 2017) .
Overall, these results indicate that PMAIP1 plays a role in the sensitivity of hPSCs to DNA damage and highlight the ability of genome-scale CRISPR screens to identify cell type-specific genes important for the fitness of pluripotent stem cells.
Genetic Screen for Suppressors of DissociationInduced Death
We next tested our ability to identify phenotypic regulators of human developmental processes. Human PSCs, unlike mouse PSCs, are very sensitive to dissociation and die in the absence of ROCK inhibitors (Ohgushi et al., 2010) . During dissociation of hPSCs, Rho and ROCK become activated. This leads to the phosphorylation of myosin, which causes membrane blebbing and cell death. To promote survival, inhibitors that target ROCK (Y-27632 or thiazovivin) or myosin (blebbistatin) are used routinely during hPSC passaging (Watanabe et al., 2007; Chen et al., 2010) . Very few cells survive dissociation in the absence of ROCK inhibitors. Importantly, this phenotype is developmentally rooted. hPSCs are epiblast-like, and cells that fail to incorporate into the polarized epithelium of the epiblast undergo cell death in the embryo (Ohgushi et al., 2010) . To gain a deeper understanding of the genes involved, we screened for suppressors of dissociation-induced death.
To ensure complete Cas9 mutagenesis, we waited till the day 14 passage of the fitness screen to plate an additional replicate of the genome-scale mutant cell library in the absence of thiazovivin ( Figures 4A and S1 ). The majority of the mutant cells died during this process, and the surviving cells were maintained for 2 weeks until large colonies were visible, at which point DNA was isolated and sgRNAs sequences were recovered by NGS. We identified 76 genes with two or more independent sgRNAs present in cells that survived dissociation without thiazovivin After 18 days of exposure to Cas9 (+dox), sgRNAs targeting TP53-related genes enrich during the screen; PMAIP1 (NOXA) (RSA À10.6, Q3 3.7), TP53 (RSA À7.64, Q3 4), and CHEK2 (RSA À3.6, Q3 2.4). A total of 302 genes have RSA scores < À3 (marked by dashed line). TP53-related genes with RSA scores < À2.25 are marked in red. The y axis is a p value generated from RSAup analysis. The x axis marks the Z score (Q3). ( Figure 4C ; Table S7 ). As expected, multiple sgRNAs targeting ROCK1 and MYH9, the genetic targets of ROCK inhibitors and blebbistatin, were recovered. Myosin is a hexameric motor protein that is composed of six subunits with three subtypes. The screen recovered three sgRNAs for MYH9, a myosin heavy chain, five sgRNAs for MYL6, a non-phosphorylated myosin light chain, and two sgRNAs for the ROCK target MYL9/MLC2, a phosphorylated myosin light chain. There are many myosin proteins, but our screen identified three of five of the most abundantly expressed in hPSCs ( Figure 4B ). This reiterates the importance of myosin activation in membrane blebbing and dissociation-induced death. A number of additional genes have roles in the actin and myosin network or cytoskeleton, including DAPK3, PAWR, OPHN1, FLII, and KIF3A ( Figure 4D ). Overall STRINGdb analysis detected a connected set of genes with ties to the actin and myosin regulatory network ( Figure 4D ). In general members of this network did not enrich during the fitness screen, suggesting that they specifically regulate dissociation-induced death and not fitness ( Figure 4E ).
PAWR Is Required for Dissociation-Induced Death
For follow-up studies, we focused on the strongest hit from the screen, the pro-apoptotic regulator PAWR (Hebbar et al., 2012) . PAWR has no known biological role in the early embryo or during dissociation-induced death of hPSCs. The screen recovered all five sgRNAs targeting PAWR in the genome-scale library, and the barcode reads were highly abundant ( Figure 4C ). Unlike sgRNAs for the TP53 pathway that enrich throughout the CRISPR screen, PAWR and MYL6 have no effect on fitness in the presence of thiazovivin ( Figure 4E ). We repeated the results using three independent lentiCRISPRs to knock out PAWR in iCas9 expressing H1-hESC cells. PAWR mutants are able to survive without thiazovivin, while control cells do not ( Figure S4 ). To independently validate these results, we used CRISPR-mediated interference (CRISPRi) to knock down the expression of PAWR mRNA without causing DNA damage or genetic mutations (Data S1) (Qi et al., 2013) . By using a H1-hESC line constitutively expressing dCas9 fused to a KRAB domain and sgRNAs targeting PAWR promoter, we also detected an increase in the survival of dissociated cells in the absence of thiazovivin ( Figure S4 ). To conduct detailed analysis of PAWR mutants, we exposed cells to Cas9 and sgRNAs targeting PAWR and generated a knockout cell line with a normal karyotype ( Figure S4 ). The suppression of dissociation-induced death is specific to PAWR mutants, as PMAIP1 mutants are unable to survive passaging without thiazovivin ( Figures 5A and 5B) . Conversely, PAWR mutants are unable to survive DSB-induced toxicity, further demonstrating the specificity of the respective phenotypes ( Figure S4E ). We next examined how PAWR mutants survive by time-lapse microscopy. After single-cell dissociation, control cells without thiazovivin exhibit membrane blebbing and subsequently die ( Figure 5C ). Conversely, PAWR mutants without thiazovivin have greatly reduced blebbing and survive as single cells by extending cell projections, which promote attachment and survival ( Figure 5C ). We further examined cytoskeletal organization using phalloidin to stain filamentous (F) actin. The thiazovivin-treated cells have an increased surface area, a fanned-out shape with actin stress fibers, and a large circular adhesion belt-like structure (Figure 5C ). In the absence of thiazovivin, control cells have many small actin rings that mark membrane blebs. PAWR mutants without thiazovivin exhibit reduced membrane blebbing and small actin rings ( Figure 5C ).
Molecularly, PAWR has dual roles as a transcriptional repressor that causes cell death and as an actin-binding protein that regulates contractility (Johnstone et al., 1996; Burikhanov et al., 2009; Vetterkind and Morgan, 2009 ). Despite having abundant PAWR mRNA, PAWR protein is post-transcriptionally regulated and induced by dissociation in hPSCs ( Figures S4 and S5 ). Immunofluorescence did not detect PAWR protein in the nucleus; however, we did observe localization of PAWR with F-actin in both thiazovivin-treated and untreated cells ( Figure 5D ). PAWR localized to adhesion belt-like structures in the presence of thiazovivin and to membrane blebs in the untreated cells after dissociation. Additional hits from the screen, PRKCZ and SCRIB, also localized to membrane blebs ( Figure S6 ). Both PRKCZ and SCRIB are expressed in the early mouse embryo and exhibit a ROCKdependent cell polarity (Kono et al., 2014) . Cumulatively, we have identified a role for PAWR in dissociation-induced death. PAWR mutants survive dissociation without ROCK inhibitors because of a failure to initiate membrane blebbing and downstream caspase activation ( Figure S5 ) (Ohgushi et al., 2010) . Furthermore, PAWR is a known pro-apoptotic factor, and we have demonstrated that PAWR protein is induced upon dissociation and colocalizes with the actin network that is responsible for initiating membrane blebbing and subsequent cell death.
FACS-Based Screen for Regulators of Pluripotency
Although our fitness screen detected a significant hPSC-specific dropout of OCT4, other critical regulators of pluripotency such as NANOG did not affect fitness ( Figure 1E ; Table S4 ). A genomescale fitness screen in mouse embryonic stem cells (mESCs) had similar results and reported the dropout of only three genes regulating blastocyst development (Koike-Yusa et al., 2014) . Pluripotency and cellular fitness of hPSCs may not be related, and this indicates that some differentiated cell types may not exhibit changes in fitness when cultured in the pluripotent media. To specifically identify regulators of human pluripotency, we conducted a FACS-based pooled screen using an OCT4 antibody. One year after conducting the first screen, we thawed a genome-scale CRISPR cell library (Àdox) and expanded the cells prior to conducting the screen ( Figure S1 ). Figure 7B ; Table S8 ). Importantly, we detected a significant enrichment of OCT4 and NANOG targeting sgRNAs in the OCT4 LOW group.
We also detected an enrichment of TGFBR1/2 genes required to maintain the culture of hPSCs and the chromatin regulators EP300 and SMARCA4/BRG1, which regulate OCT4 expression and function in hPSCs (Singhal et al., 2010; Chen et al., 2011; Wang et al., 2012; King and Klose, 2017) . Using STRINGdb, we identified a core network of genes connected to OCT4 in the OCT4 LOW group ( Figure 6C ). This highlights the ability of phenotypic CRISPR screening to identify relevant gene networks. Additionally, the OCT4 HIGH group identified factors that promote differentiation, such as HAND1, KDM5B, and EIF4G2 (Table S8) (Yamanaka et al., 2000; Hough et al., 2006; Kidder et al., 2013) . Many of the genes in these lists have published roles in regulating pluripotency, reprogramming or embryonic development, and further investigation of the less studied genes will reveal insights into the human pluripotent state (Tables S8  and S9 ). See also Figure S1 .
ever, the static state of these cells has revealed less about genes with developmental functions (Hart et al., 2015) . To compare hPSC results to cancer cell lines, we conducted pairwise Pearson correlation coefficients using Bayes factor distributions (cancer data from Hart et al., 2015) . The analysis revealed that hPSCs formed a distinct cluster (Figure 7A ) and is consistent with the partial overlap between core-essential genes in cancer and fitness genes in hPSCs (52%; Figure 1E ). To focus on gene networks specific to hPSCs, we conducted bioinformatics analysis comparing 829 core-essential cancer genes (essential for five of five cell lines; Hart et al., 2015) with hPSC-specific gene sets identified by our screens. A total of 661 hPSC-specific genes were obtained from the fitness screen (365 depleted and 20 enriched p53-related genes), dissociation-induced death screen (76), and the OCT4 FACS screen (212) ( Table S10 ). The gene lists were analyzed using the PANTHER classification system (pantherdb.org). PANTHER pathway analysis identified a greater diversity of 92 enriched pathways in hPSCs and only 38 in the cancer lines ( Figure 7B ). In accordance with this, we also detected an increase in the number of genes with receptor and signal transducer activity molecular functions ( Figure 7C ). The hPSCenriched pathways included several expected regulators: FGF, TGF-beta, and WNT ( Figure 7B ). FGF2 and TGFb are critical components of E8 media and are required to maintain pluripotency in vitro (Chen et al., 2011) . WNT signaling regulates both differentiation and pluripotency in ESCs (Sokol, 2011) . Activation of EGF, PDGF, and VEGF is also important for the maintenance of the pluripotent state in (Figure 7B ) (Brill et al., 2009 ). P53 and CCKR/Rho GTPases pathways, which regulate apoptosis and have critical roles in determining the sensitivity of hPSCs to DNA damage and enzymatic dissociation, were also enriched ( Figure 7B) . Examination of the biological processes' gene ontology revealed an increase in the number of development and multicellular organism genes ( Figure 7C ). Furthermore, sub-dividing the developmental process category revealed enrichment of genes regulating cell death, differentiation, and early developmental stages ( Figure 7C ). Globally these results highlight the identification of cell type-specific genes regulating different aspects of the pluripotent state. By screening for regulators of three fundamental processes governing the culture of hPSCs, we have successfully identified known regulators in addition to a plethora of genes involved in stem cell biology ( Figure 7D ). These genes are a blueprint for human pluripotency and will serve as a useful resource for the human development and stem cell communities.
DISCUSSION
The use of hPSCs in large-scale functional genomics studies has been limited by technical constraints. Prior to our study, it was unclear that genome-scale CRISPR screens were possible in hPSCs, as the first attempts had poor performance (Hart et al., 2014; Shalem et al., 2014) . We overcame this by building a high-performance two-component CRISPR/CAS9 system for hPSCs. The performance, across many sgRNAs, made the platform amenable to high-throughput screening. Using iCas9 in hPSCs it is possible to perturb hundreds of genes in arrayed format or the entire genome in pooled format. The system is renewable, and a pool of stem cells with sgRNAs to the entire genome can be banked, distributed, and used for successive screens in hPSCs and their differentiated progeny. Beyond technical proficiency, we identified genes that regulate fundamental stem cell processes such as self-renewal, their inherent sensitivity to DNA damage, single-cell cloning, pluripotency, and differentiation. First, we identified 770 genes required for the self-renewal of hPSC. A majority of these genes have established roles in fitness, while 365 of these genes are specific to hPSCs. This set of genes could be used to inform a systematic approach to improve the consistency, robustness, and user-friendliness of hPSC culture conditions. During the fitness screen, we also determined that Cas9 activity imposes selective pressure on DNA damage-sensitive hPSCs. This caused the enrichment of 20 genes that are connected to TP53. Consistent with this, dominant-negative TP53 mutations and deletions recurrently occur and provide a selective advantage during the culture of hPSCs (Amir et al., 2017; Merkle et al., 2017) . In addition to TP53, we identified a hPSC-specific role for PMAIP1 in determining the extreme sensitivity of hPSCs to DNA damage. Like TP53, deletions of chromosome 18 spanning the PMAIP1 locus have been recurrently observed during hPSC culture (Amps et al., 2011) and suggest that PMAIP1 deletion may be responsible for enhanced survival of these lines. These TP53-related genes have the potential to improve the efficiency or safety of genome engineering through transient inhibition or by monitoring their spontaneous mutation rate during hPSC culture (Merkle et al., 2017; Ihry et al., 2018) . Second, we identified 76 genes that enhance the survival of hPSCs during single-cell dissociation. Collectively, the screen uncovered an actin and myosin network required for membrane blebbing and cell death caused by dissociation. We identified a role for PAWR, a pro-apoptotic regulator that is induced upon dissociation. PAWR is required for membrane blebbing and subsequent death of dissociated hPSCs in the absence of ROCK inhibitors. Importantly, the results are developmentally relevant, and we also identified SCRIB and PRKCZ, which are known regulators of cell polarity in the early mouse embryo (Kono et al., 2014) . PAWR has been shown to physically interact with PRKCZ and suggests a potential link between cell polarity and dissociation-induced death (Díaz-Meco et al., 1996) . These hits appear to be related to the polarized epiblast-like state of primed hPSC and could explain why polarized hPSCs are sensitive to dissociation, whereas unpolarized naive mESCs are not (Takashima et al., 2015) . Last, this set of genes could enable focused approaches to improve the single-cell cloning efficiencies of hPSCs and the culture of naive hPSCs.
In the final screen, by subjecting our hPSC CRISPR library to FACS sorting on OCT4 protein, we identified 113 genes that are required to maintain pluripotency and 99 genes that potentially regulate differentiation. Overall, the screen identified an entire network of genes related to OCT4. Nineteen of these genes have previously indicated roles in pluripotency, embryo development, and reprogramming (Table S9 ). Future studies on the genes in the list will yield new insights about the genetic control of pluripotency and differentiation. These gene sets could guide rational improvements to protocols for the maintenance, differentiation, and reprogramming of hPSCs.
Overall, the results highlight the ability of unbiased genomescale screens to identify critical and regulators of hPSC biology. Importantly, some of the strongest hits, such as PAWR and PMAIP1, were also identified in haploid hPSC screens (Yilmaz et al., 2018) . Future investigation into the genes provided by these screens will be a step toward the genetic dissection of the human pluripotent state. Herein we provide simple and scalable work flows that will lower the entry barrier for additional labs to conduct large-scale CRISPR screens in hPSCs. The scalable and bankable platform described here is a renewable resource that will allow successive screens and the distribution of CRISPR-infected hPSC libraries. We anticipate that the use of CRISPRi will improve the performance. Reducing Cas9-induced toxicity will limit artifacts and reduce need for high library coverage and costs to enable systematic screening in many independent hPSC lines and differentiated cell types. The platform could potentially be used to improve the generation, culture, and differentiation capacity of hPSCs. It can be applied to the study of development and disease in wide variety of differentiated cell types. Established protocols for neurons, astrocytes, cardiomyocytes, hepatocytes, and beta cells can be exploited to dissect the genetic nature of development and homeostasis in disease-relevant cell types. This resource opens the door for the systematic genetic dissection of disease-relevant human cells in way that was only before possible in model organisms.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: K2A ) and 75.6 ug of the lentiCRISPR plasmid library was added to the transfection mix and incubated for 15 minutes at room temp. After incubation, the mix was added to 100 mL of fresh media and the cells were fed. The next day the transfected cells received 100 mL fresh media. After 3 days of viral production supernatants were filtered (.45uM corning 430516) and aliquoted in to 1ml tubes for storage at À80 C.
Large-scale transduction of hPSCs
We conducted a genome-scale CRISPR screen using a 91,726 sgRNA library ($5 sgRNAs per gene, split into two sgRNA sub-pools (DeJesus et al., 2016) . We desired > 1000x coverage of each sgRNA to offset cell loss from double strand break (DSB)-induced toxicity . To screen a sufficient number of cells we infected hPSCs with lentiCRISPRs in 5-layer CellSTACKs. Cells were infected at 0.5 MOI to ensure each cell was infected with no more than a single sgRNA. After puromycin selection cells were expanded for one week without dox to be pelleted for DNA, banked or screened ( Figures 1A and S1 ). Pooled CRISPR screens rely on cells being efficiently transduced at less than or equal to 0.5 MOI. We developed a reverse transfection method for hPSCs without polybrene that resulted in an efficient transduction with low volume exposure to HEK293T lentiviral supernatants. LentiCRISPR plasmids expressed a constitutive RFP and puromycin resistance to mark and select for infected cells respectively. Viral titer of the two $45,000 sgRNA libraries expressing RFP in 6-well plates determined that less than 25 uL in 1.5mL of media was required for 0.5 MOI. These calculations scaled appropriately in 5-layer cell stacks with 500 mL of media and approximately 50% of the cells were RFP positive in the absence of puromycin.
A genome-scale lentiCRISPR library targeting each gene 5 times has been split into $45,000 sub-pools (pool 1 and 2). To screen at > 1000x per sgRNA, 264 million hPSCs are infected in 4x 5-layer CellSTACKS (12,720 cm 2 , 21,000 cells/ cm 2 ). 2 stacks equal one replicate. Cells are infected at 0.5 MOI to ensure only one sgRNA is expressed per cell (+sgRNA/puro R /RFP). After puromycin selection cells are expanded until confluent (4-6 days). At this point 40 million cells (10 million/ml) can be banked in 5ml cryovials for use at a later date.
Banking lentiCRISPR infected hPSC library
One 5-layer cell stack was treated with 200 mL accutase that was evenly distributed among layers. After incubation at 37 C for 10 minutes, accutase (GIBCO-A1110501) was neutralized with 200 mL E8 media. Cells were counted and pelleted to be resuspended at a concentration of 10 million cells per ml in a solution of 40% Tet-free FBS (Seradigm #1500-500) and 10% DMSO (Sigma D2650) and 50% E8 media. 4 mL aliquots were placed in 5 mL cryovials and frozen in a Mr. Frosty (Thermo Scientific 5100-0050) at À80 C overnight before long-term storage in liquid nitrogen. Thawing of cells banked in 5ml cryovials showed an average viability around 85% for both lentiCRISPR pools. Viability was assayed using a Nexcelom Cellometer Auto 2000 and AO/PI (Nexcelom CS2-0106) staining solution.
We tested the effect of freezing and thawing on the representation of the sgRNAs in the library by thawing the cell library at 2700x (120 million cells per 45k sub-pool) cells per sgRNA. Cells were thawed in a 37 C water bath and transferred to a 50 mL conical with E8 media and centrifuged at 300 g for 3 minutes. Pelleted cells were resuspended in E8 media and replated at a density of 40,000 to 60,000 cells/cm 2 . 3 cryovials with 120 million cells was thawed and plated on a 5-layer cell stack (120,000,000 /45,000 = 2700x). After thawing and feeding the cells for two days, DNA was isolated and analyzed by NGS to measure the representation of each sgRNA in the pool. Both day zero and freeze/thaw samples had an over 87% alignment of sequencing reads and fewer than 25 missing barcodes per replicate. Pearson correlation analysis allowed us to demonstrate that there was a high correlation between the day zero samples and the freeze/thaw samples. Calculating normalized sgRNA counts revealed a strong correlation between the cell library before (day 0) or after one freeze/thaw cycle ( Figure 1B ).
Pooled Mutagenesis (CRISPR nuclease/interference) H1-hESCs expressing a constitutive (c) Cas9-KRAB knocked-in to the AAVS1 locus were generated as described by Ihry et al. (2018) . The following lentiCRISPR were used to transduce iCas9 or cCas9-KRAB cells to generate mutant cell pools.
CRISPR nuclease
PAWR sgRNA 1 TTTGGGAATATGGCGACCGG PAWR sgRNA 2 GGTGGCTACCGGACCAGCAG PAWR sgRNA 5 CGAGCTCAACAACAACCTCC MAPT sgRNA 1 GAAGTGATGGAAGATCACGC ACSL4 sgRNA TGGTAGTGGACTCACTGCAC ARSH sgRNA GCAGCACCGTGGCTACCGCA BMX sgRNA ATGAAGAGAGCCGAAGTCAG BTK sgRNA GGAATCTGTCTTTCTGGAGG GABRA3 sgRNA AAGGACTGACCTCCAAGCCC GK sgRNA TAGAAAGCTGGGGCCTTGGA NRK sgRNA CGCCTTCCTATTTCAGGTAA TLR7 sgRNA CAGTCTGTGAAAGGACGCTG
CRISPR interference
Control-2 GACCGGAACGATCTCGCGTA PAWR sgRNA 1 GGCGCGCTCGAGGACTCCAA PAWR sgRNA 2 GTTGCAGGGTGGGGACCCGG PAWR sgRNA 3 GCTGGCCGGTAGTGACTGGT PAWR sgRNA 5 GGCTGCTGGCCGGTAGTGAC OCT4 FACS-BASED screen Cells were dissociated using accutase for 10 min at 37 C to create a single-cell suspension which was strained using a 40-micron filter and was counted. After removing accutase, pelleted cells were resuspended in a volume of 1 million cells/mL for the staining protocol. For each replicate 55 million unsorted cells were frozen down prior to fixation. The remaining cells were fixed in 4% PFA in PBS for 10 minutes at room temperature on a rocker. Cells were spun down at 300 RCF for 3 min between each subsequent solution change. Cells were washed with 0.1% Triton-X in PBS after fixation and blocked in 2% goat serum, 0.01% BSA and 0.1% triton X in PBS for 1hr at room temperature. Conjugated (AF488) primary antibodies specific to OCT4 (CST 5177) were diluted in blocking solution (1:200) and incubated with cells on a rocker over night at 4 C. Prior to FACS analysis cells were resuspended in PBS at a concentration of 30 million cells/mL. A total of 1.2 billion cells (both replicates) were sorted into OCT4 low (50 million cells) and OCT4 high (61 million cells) populations using an ARIA III (BD).
DNA isolation and NGS libraries
For each replicate, 55 million cells ($1200x) were pelleted and genomic DNA was isolated using QIAamp DNA Blood Maxi Kit (QIAGEN 51194) as directed by manufacturer. Isolating genomic DNA from 4% PFA fixed cells was performed by utilizing phenol chloroform extraction. Cells were resuspended in 500ul TNES (10mM Tris-Cl ph 8.0, 100mM NaCL, 1mM EDTA, 1% SDS) and incubated overnight at 65 C. After allowing the samples to cool, 10ul of RNase A (QIAGEN 19101) and samples were incubated at 37 C for 30 minutes. Next, 10ul of proteinase K (QIAGEN 19133) and incubated for 1 hour at 45 C. Add 500ul of PCIA (Phenol;Cholorform; Isoamyl alcohol ph 8) (Thermo 17908) and vortex. Spin samples in a centrifuge at max speed for 2 minutes. Transfer the aqueous phase to 500ul of PCIA and vortex. Spin at max speed for 2 minutes. Transfer the aqueous phase to 450ul of chloroform and vortex. Spin at max speed for 2 minutes. Transfer aqueous phase to 40ul of 3M NaAcO ph 5.2. Add 1 mL of 100% ethanol, mix and precipitate DNA for 1 hour on ice. Spin at max speed for 2 minutes. Decant and wash with 1ml 70% ethanol. Spin at max speed for 1 minutes. Decant and air dry the pellet. Resuspend in 50ul of nuclease free H 2 0. PCR was performed using lentiCRISPR specific primers and library construction and sequencing was performed as described by DeJesus et al. (2016) .
mRNA expression qPCR and RNA-seq analysis were performed as described by Ihry et al. (2018) . Median TPM values for H1-hESCs are available upon request. RNA-seq data for in 4 iPSC control lines subjected to NGN2 differentiation is available upon request but is restricted to the expression for PAWR and PMAIP1.
Assaying sensitivity to DNA damage Control and mutant iCas9 H1-hESCs expressing a MAPT targeting sgRNA were monitored daily post-media change using an IncuCyte zoom (Essen Biosciences). At the onset of the experiment cells were plated at density of 10,500 to 21,000 cells/cm [2] and cultured plus or minus dox for the duration. Confluence was calculated using the processing analysis tool (IncuCyte Zoom Software).
Figures 1D, 2A, and 6B Redundant siRNA activity (RSA) analysis is a statistical method used to calculate a p values based on the activity ranked distribution of all sgRNAs targeting a single gene (https://admin-ext.gnf.org/publications/RSA/, https://admin-ext.gnf.org/ publications/RSA/RSA_tutorial.pdf). This probability-based method favors genes with multiple active sgRNAs over a single but very active sgRNA. RSA scores each gene by identifying a bias in the distribution of sgRNAs targeting that gene. Two replicates per condition were sequenced and the raw sgRNAs counts for the genome-wide library ($91,000 sgRNAs) were used to calculate log2(fold change) by DESeq2 (Love, Huber and Anders, 2014) . Log2(fold changes) for the entire sgRNA library were used as the ranked distribution for RSA analysis. In this study two independent replicates with high coverage ($1000 cells per sgRNA) were chosen because hPSC media is prohibitively expensive at genome-scale for the month-long screen.
Figure 1E
The BAGEL statistical model was used to calculate Bayes Factor scores and Precision Recall analysis (http://bagel-forknockout-screens.sourceforge.net/). Log2(Fold Change) of raw sgRNA counts were used as input to for BAGEL analysis.
Figures 3B and 3E
Statistical analysis of relative expression values generated by qPCR for PMAIP1 (3B) P21 (3E) and FAS (3E) mRNAs was conducted using PRISM software (version 7.0c). Relative expression values for control and treated samples were tested for statistical differences by conducting an ordinary an unpaired two tailed t test with equal variance. n = 3 for control and treated mRNA samples isolated from 3 independent wells are plotted as individual dots. Bars indicate mean and error bars depict standard deviation. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Figure 3A and S4F Differential gene expression was performed in R with DESeq2 which is suitable for studies with three replicates (n = 3), and maintains high precision and sensitivity (Love, Huber and Anders, 2014) . Gene counts are normalized for library size using the geometric mean and modeled with a negative binomial distribution. RNA was isolated from 1-4 independent samples for both control and Ngn2 neuronal samples in different hPSC backgrounds (H1-hESCs (n = 1), H9-hESCs (n = 3), 8402-iPSCs (n = 3) and HDFn-iPSCs (n = 4)).
DATA AND SOFTWARE AVAILABILITY
RNaseq data in hPSCs and Ngn2 neurons is limited to the expression of PMAIP1 and PAWR and is available upon request. Normalized sgRNA counts, Log2(fold changes) and RSA analysis for pooled CRISPR screens in H1-hESCs are available in Tables S1, S2 , S3, S5 and S8. Pooled CRISPR screening data in cancer cell lines is limited to Log2(fold changes) for PMAIP1 sgRNAs and is available upon request. RNA-seq data processing and pooled CRISPR NGS were conducted using open source software as indicated in the key resources table.
